Meeting report from the joint IARC-NCI international cancer seminar series: a focus on colorectal cancer.


Journal

Annals of oncology : official journal of the European Society for Medical Oncology
ISSN: 1569-8041
Titre abrégé: Ann Oncol
Pays: England
ID NLM: 9007735

Informations de publication

Date de publication:
01 04 2019
Historique:
pubmed: 6 2 2019
medline: 21 4 2020
entrez: 6 2 2019
Statut: ppublish

Résumé

Despite significant progress in our understanding of the etiology, biology and genetics of colorectal cancer, as well as important clinical advances, it remains the third most frequently diagnosed cancer worldwide and is the second leading cause of cancer death. Based on demographic projections, the global burden of colorectal cancer would be expected to rise by 72% from 1.8 million new cases in 2018 to over 3 million in 2040 with substantial increases anticipated in low- and middle-income countries. In this meeting report, we summarize the content of a joint workshop led by the National Cancer Institute and the International Agency for Research on Cancer, which was held to summarize the important achievements that have been made in our understanding of colorectal cancer etiology, genetics, early detection and treatment and to identify key research questions that remain to be addressed.

Identifiants

pubmed: 30721924
pii: S0923-7534(19)31125-1
doi: 10.1093/annonc/mdz044
pmc: PMC6503626
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

510-519

Subventions

Organisme : Department of Health
ID : 04/33/01
Pays : United Kingdom
Organisme : Department of Health
ID : 09/22/192
Pays : United Kingdom
Organisme : Department of Health
ID : 11/136/120
Pays : United Kingdom
Organisme : Department of Health
ID : HTA/16/65/01
Pays : United Kingdom

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of the European Society for Medical Oncology.

Références

Nat Med. 2015 Nov;21(11):1350-6
pubmed: 26457759
Int J Cancer. 2011 Apr 1;128(7):1668-75
pubmed: 20503269
mBio. 2013 Nov 05;4(6):e00692-13
pubmed: 24194538
Br J Cancer. 2018 Mar 20;118(6):920-929
pubmed: 29520109
J Natl Cancer Inst. 2010 Jul 21;102(14):1012-22
pubmed: 20587792
Gut. 2015 Oct;64(10):1637-49
pubmed: 26041752
Ann Intern Med. 2013 Jul 16;159(2):77-85
pubmed: 23856681
JAMA. 2014 Aug 13;312(6):606-15
pubmed: 25117129
BMJ. 2015 Jan 02;350:g7607
pubmed: 25555821
Nat Genet. 2008 Dec;40(12):1426-35
pubmed: 19011631
Gastroenterology. 2013 Apr;144(4):799-807.e24
pubmed: 23266556
Gastrointest Cancer Res. 2012 Jan;5(1):19-27
pubmed: 22574233
N Engl J Med. 2003 Mar 6;348(10):919-32
pubmed: 12621137
Gut. 2013 Jun;62(6):871-81
pubmed: 22490517
Cancer Causes Control. 2013 Jun;24(6):1207-22
pubmed: 23563998
Nat Genet. 2013 Feb;45(2):136-44
pubmed: 23263490
J Clin Oncol. 2012 Nov 10;30(32):3983-90
pubmed: 23008295
Lancet Diabetes Endocrinol. 2018 Feb;6(2):95-104
pubmed: 29195904
Nat Biotechnol. 2017 Nov;35(11):1077-1086
pubmed: 28967885
Lancet. 2018 May 26;391(10135):2128-2139
pubmed: 29754777
Science. 2006 Sep 29;313(5795):1960-4
pubmed: 17008531
Nat Genet. 2013 Feb;45(2):191-6
pubmed: 23263487
JAMA Oncol. 2016 Sep 1;2(9):1197-206
pubmed: 27148825
Acta Oncol. 2013 Jun;52(5):919-32
pubmed: 23581611
Cancer Epidemiol Biomarkers Prev. 2015 Jul;24(7):1024-31
pubmed: 25976416
Lancet Oncol. 2010 Feb;11(2):165-73
pubmed: 20005175
Cancer Epidemiol Biomarkers Prev. 2014 Sep;23(9):1712-28
pubmed: 25004920
Nat Genet. 2007 Aug;39(8):984-8
pubmed: 17618284
J Pharmacol Exp Ther. 2000 Apr;293(1):166-71
pubmed: 10734166
Am J Gastroenterol. 2015 Sep;110(9):1359-66
pubmed: 26303133
N Engl J Med. 2015 Jun 25;372(26):2509-20
pubmed: 26028255
N Engl J Med. 2004 Mar 4;350(10):991-1004
pubmed: 14999111
Dig Liver Dis. 2014 Jan;46(1):82-6
pubmed: 24011791
BMJ. 2017 Oct 31;359:j4761
pubmed: 29089348
Genet Epidemiol. 2013 Sep;37(6):603-13
pubmed: 23873611
Dtsch Arztebl Int. 2016 Feb 19;113(7):101-6
pubmed: 26940777
JAMA Oncol. 2015 Aug;1(5):653-61
pubmed: 26181352
Nat Genet. 2012 May 06;44(6):699-703
pubmed: 22561515
CA Cancer J Clin. 2018 Jul;68(4):250-281
pubmed: 29846947
Science. 2013 Mar 29;339(6127):1546-58
pubmed: 23539594
Lancet. 2017 Apr 1;389(10076):1299-1311
pubmed: 28236467
Cancer. 2015 Sep 15;121(18):3221-9
pubmed: 25995082
N Engl J Med. 2018 May 03;378(18):1734-1740
pubmed: 29580179
BMC Cancer. 2010 Dec 04;10:670
pubmed: 21129217
BMJ. 2014 Apr 09;348:g2467
pubmed: 24922745
N Engl J Med. 2007 May 24;356(21):2131-42
pubmed: 17522398
Cancer Discov. 2018 Jun;8(6):730-749
pubmed: 29510987
Ann Intern Med. 2014 Feb 4;160(3):171
pubmed: 24658694
Am J Hum Genet. 2016 Aug 4;99(2):337-51
pubmed: 27476653
PLoS Genet. 2014 Apr 17;10(4):e1004228
pubmed: 24743840
Science. 2017 Dec 15;358(6369):1443-1448
pubmed: 29170280
J Natl Cancer Inst. 2002 Dec 4;94(23):1763-72
pubmed: 12464648
Gastroenterology. 2015 Jun;148(7):1330-9.e14
pubmed: 25683114
N Engl J Med. 2000 Jul 13;343(2):78-85
pubmed: 10891514
Nat Genet. 2015 Jun;47(6):668-71
pubmed: 25938944
Inflamm Res. 2018 May;67(5):375-389
pubmed: 29322204
Int J Cancer. 2012 May 15;130(10):2387-96
pubmed: 21671473
CA Cancer J Clin. 2017 May 6;67(3):177-193
pubmed: 28248415
Gut. 2011 Mar;60(3):397-411
pubmed: 21036793
N Engl J Med. 2016 Aug 25;375(8):794-8
pubmed: 27557308
Gastroenterology. 2010 Mar;138(3):877-85
pubmed: 19932107
J Natl Cancer Inst. 2013 Dec 18;105(24):1907-11
pubmed: 24316595
Ann Oncol. 2013 Oct;24 Suppl 6:vi64-72
pubmed: 24078664
Clin Transl Gastroenterol. 2017 Apr 27;8(4):e91
pubmed: 28448072
N Engl J Med. 2003 Mar 6;348(10):883-90
pubmed: 12621132
Front Public Health. 2017 Jul 24;5:179
pubmed: 28791283
Mol Cells. 2014 May;37(5):365-71
pubmed: 24781408
Gut. 2017 Apr;66(4):683-691
pubmed: 26818619
Lancet. 2010 May 8;375(9726):1624-33
pubmed: 20430429
Gut. 2006 Feb;55(2):205-11
pubmed: 16188921
Cancer Res. 2012 Apr 15;72(8):2036-44
pubmed: 22367214
Int J Cancer. 2018 Aug 1;143(3):527-534
pubmed: 29479691
Clin Cancer Res. 2009 Oct 15;15(20):6412-20
pubmed: 19825961
Nat Genet. 2007 Nov;39(11):1315-7
pubmed: 17934461
Lancet. 2018 Mar 17;391(10125):1023-1075
pubmed: 29395269
J Natl Cancer Inst. 2019 Feb 1;111(2):158-169
pubmed: 29912394
J Pathol Clin Res. 2017 Jul 19;3(3):203-213
pubmed: 28770104
Nat Genet. 2019 Jan;51(1):76-87
pubmed: 30510241
Risk Manag Healthc Policy. 2017 Dec 04;10:177-187
pubmed: 29270036
Gastrointest Endosc. 2012 Mar;75(3):612-20
pubmed: 22341106
Gastroenterology. 2018 Jun;154(8):2152-2164.e19
pubmed: 29458155
Clin Gastroenterol Hepatol. 2012 Jun;10(6):639-45
pubmed: 22289873
Ann Saudi Med. 2015 May-Jun;35(3):189-95
pubmed: 26409792
JAMA Intern Med. 2016 Jun 1;176(6):816-25
pubmed: 27183032
Hum Genet. 2012 Feb;131(2):217-34
pubmed: 21761138
PLoS One. 2012;7(6):e39743
pubmed: 22761885
J Clin Oncol. 2008 Jul 1;26(19):3213-21
pubmed: 18591556
Nat Rev Gastroenterol Hepatol. 2018 Nov;15(11):659-670
pubmed: 29970888
Br Med Bull. 2013;105:29-42
pubmed: 23299409
N Engl J Med. 1988 Sep 1;319(9):525-32
pubmed: 2841597
Int J Cancer. 2013 Oct 15;133(8):1914-25
pubmed: 23494461
J Natl Cancer Inst. 2015 Jul 23;107(10):
pubmed: 26206950
Nat Genet. 2008 May;40(5):631-7
pubmed: 18372901
Science. 2013 Jun 7;340(6137):1190-4
pubmed: 23744940
Nature. 2012 Jul 18;487(7407):330-7
pubmed: 22810696
Int Immunopharmacol. 2012 Jan;12(1):10-20
pubmed: 22172645
Gut. 2012 Jul;61(7):1036-40
pubmed: 22052062
N Engl J Med. 2013 Sep 19;369(12):1106-14
pubmed: 24047060
JAMA. 2009 Aug 12;302(6):649-58
pubmed: 19671906
Nat Genet. 2010 Nov;42(11):973-7
pubmed: 20972440
Expert Opin Biol Ther. 2017 Jun;17(6):709-721
pubmed: 28375039
Eur J Cancer. 2013 Sep;49(14):3049-54
pubmed: 23706981
Cancer Immunol Res. 2017 Nov;5(11):942-949
pubmed: 29038296
Endoscopy. 2013;45(1):51-9
pubmed: 23212726
J Natl Compr Canc Netw. 2015 May;13(5 Suppl):682-5
pubmed: 25995430
Gut. 2019 Apr;68(4):672-683
pubmed: 29615487
Lancet. 2011 Dec 17;378(9809):2081-7
pubmed: 22036019
N Engl J Med. 2003 Mar 6;348(10):891-9
pubmed: 12621133
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
J Natl Cancer Inst. 2019 Feb 1;111(2):146-157
pubmed: 29917119
J Natl Cancer Inst. 2010 Mar 17;102(6):365-7
pubmed: 20208016
Gastroenterology. 2010 Jun;138(6):2044-58
pubmed: 20420945
Carcinogenesis. 2017 Aug 1;38(8):781-788
pubmed: 28582482
Lancet. 2017 Dec 16;390(10113):2627-2642
pubmed: 29029897
Mol Syst Biol. 2014 Nov 28;10:766
pubmed: 25432777
Nat Med. 2017 Jul;23(7):878-884
pubmed: 28628110
Hum Genet. 2013 Feb;132(2):219-31
pubmed: 23114982
Diagn Interv Imaging. 2014 May;95(5):467-74
pubmed: 24794252

Auteurs

M J Gunter (MJ)

Section of Nutrition and Metabolism, International Agency for Research on Cancer, Lyon, France. Electronic address: GunterM@iarc.fr.

S Alhomoud (S)

King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.

M Arnold (M)

Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France.

H Brenner (H)

Division of Clinical Epidemiology and Aging Research, Division of Preventive Oncology and German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg; National Center for Tumor Diseases (NCT), Heidelberg, Germany.

J Burn (J)

Institute of Genetic Medicine, Newcastle University, Newcastle, UK.

G Casey (G)

Center for Public Health Genomics, University of Virginia, Charlottesville.

A T Chan (AT)

Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, USA.

A J Cross (AJ)

School of Public Health, Imperial College London, London, UK.

E Giovannucci (E)

Harvard T.H. Chan School of Public Health, Boston.

R Hoover (R)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, USA.

R Houlston (R)

Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK.

M Jenkins (M)

Centre for Epidemiology and Biostatistics, University of Melbourne, Melbourne, Australia.

P Laurent-Puig (P)

SIRIC CARPEM, APHP European Georges Pompidou Hospital Paris, Universite Paris Descartes, Paris, France.

U Peters (U)

Public Health Science Division, Fred Hutchinson Cancer Research Center, Seattle.

D Ransohoff (D)

Lineberger Comprehensive Cancer Center, UNC School of Medicine, University of North Carolina, Chapel Hill.

E Riboli (E)

School of Public Health, Imperial College London, London, UK.

R Sinha (R)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, USA.

Z K Stadler (ZK)

Memorial Sloan Kettering Cancer Center, New York, USA.

P Brennan (P)

Section of Genetics, International Agency for Research on Cancer, Lyon, France.

S J Chanock (SJ)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH